Nigeria’s men’s cricket team, the Yellow Greens, began their ICC T20 World Cup Sub-Regional Qualifier C campaign in spectacular fashion, cruising to a 118-run victory over St Helena at the Moshood Abiola National Stadium in Abuja on Saturday. Batting first, Nigeria posted an imposing 185/2 in their 20 overs, with decisive contributions from their top-order batters. In response, St Helena struggled to gain any foothold, bowled out for just 67 runs in 19.1 overs, as Nigeria’s bowling attack proved too strong to handle. The resounding win cements the Yellow Greens’ status as tournament favourites, especially as the highest-ranked team in the qualifiers at 36th on the ICC T20 rankings. The victory also underscores head coach Steve Tikolo’s ambitions for the side to not just qualify but dominate the qualifiers en route to the final phase. “Our goal is not just to qualify but to win the tournament and prepare for the next round as champions,” Tikolo said before the tournament opener. Related News Cricket: Nigeria begin T20 W’Cup qualifiers against St Helena Cricket: Nigeria’s opponents arrive for W’Cup qualifiers W’Cup qualifiers: Tikolo rates Nigeria’s opponents high In other games played on Saturday, Botswana defeated Eswatini by 45 runs, scoring 172/4 in their 20 overs before dismissing their opponents for 124 in 18.4 overs. Meanwhile, Sierra Leone showcased an even more emphatic display, thrashing Ivory Coast by a staggering 168 runs. Sierra Leone posted 188/2 in their 20 overs and skittled out the Ivorians for a paltry 20 runs in just 10.4 overs. The Yellow Greens will next face Eswatini on Monday before meeting Sierra Leone on Tuesday and Botswana on Wednesday in what promises to be a competitive round of matches. The top two teams from this sub-regional qualifier will advance to the final phase, where two spots are up for grabs to represent Africa at the 2026 ICC T20 World Cup alongside South Africa. With home support and their sights firmly set on World Cup qualification, the Yellow Greens have started their campaign on a commanding note, showcasing their intent to dominate on their home turf.AP Trending SummaryBrief at 6:30 p.m. EST

Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports, and conference presentations. Investors next week will see a rush of economic indicators ahead of the Thanksgiving holiday in the US on Thursday, including the second estimate of Q3 GDP and durable goods orders for November. Also scheduled is data on new home sales in October and regional economic readings from the Fed’s branches in Chicago, Dallas, and Richmond. In the holiday shortened week, some higher-profile tech names are scheduled to replace their latest quarterly results, including Dell Technologies ( DELL ), CrowdStrike Holdings ( CRWD ), Autodesk ( ADSK ), Zoom Video Communications ( ZM ), and Analog Devices ( ADI ). Earnings spotlight: Monday, November 25 - Agilent Technologies ( A ), Zoom Video Communications ( ZM ), Woodward ( WWD ), Bath & Body Works ( BBWI ), and Semtech ( SMTC ). See the full earnings calendar . Earnings spotlight: Tuesday, November 26 - Analog Devices ( ADI ), Dell Technologies ( DELL ), CrowdStrike Holdings ( CRWD ), Guess? ( GES ), Manchester United ( MANU ), Workday ( WDAY ), and Autodesk ( ADSK ). See the full earnings calendar . Earnings spotlight: Wednesday, November 27 - Patterson Companies ( PDCO ), and Zuora ( ZUO ). See the full earnings calendar . Earnings spotlight: Friday, November 29 - MINISO Group Holding ( MNSO ) and Frontline ( FRO ). See the full earnings calendar . Volatility watch: MicroStrategy ( MSTR ) heads the list of options trading with high implied volatility amid bankruptcy speculation. The most overbought stocks per their 14-day relative strength index include Zion Oil ( OTCQB:ZNOG ), Honest Company ( HNST ), and AppLovin ( APP ). The most oversold stocks per their 14-day Relative Strength Index include Juniper ( JNPR ), Celanese ( CE ), and Regeneron ( REGN ). Short interest is elevated on Immunitybio ( IBRX ) and Enovix ( ENVX ). IPO watch: Youxin Technology (

Published 4:27 pm Saturday, November 30, 2024 By Data Skrive Foster Moreau was a limited participant in his most recent practice. The New Orleans Saints’ Week 13 matchup against the Los Angeles Rams begins at 4:05 PM ET on Sunday. Take a look at Moreau’s stats below. Moreau’s season stats include 217 yards on 15 receptions (14.5 per catch) and three touchdowns. He has been targeted 21 times. Don’t miss a touchdown this NFL season. Catch every score with NFL RedZone on Fubo. What is Fubo? Fubo is a streaming service that gives you access to your favorite live sports and shows on demand. Start your risk free trial today and watch seven hours of commercial-free football from every NFL game every Sunday. BetMGM is one of the most trusted Sportsbooks in the nation. Start with as little as $1 and place your bets today . Catch NFL action all season long on Fubo. Not all offers available in all states, please visit BetMGM for the latest promotions for your area. Must be 21+ to gamble, please wager responsibly. If you or someone you know has a gambling problem, contact 1-800-GAMBLER .

Peter Dutton will use a private Coalition meeting to calm MPs fearful that Labor’s teen social media ban is a Trojan Horse for government control of the internet, ahead of a sitting week in which the major parties plan to ram the legislation through parliament. On Friday Coalition MPs were called to a Monday morning gathering in Canberra, party sources said, where Dutton and communications spokesman David Coleman planned to field questions about Labor’s proposed law to ban children under 16 from platforms such as TikTok and Instagram. Opposition Leader Peter Dutton and communications spokesman David Coleman will face concerned MPs. Credit: Louise Kennerley Right-wing Coalition senators Matt Canavan and Alex Antic have been sharply critical of the bill’s potential to require Australians to give tech giants their IDs and the power it would give the eSafety Commission, which is a federal agency that will be charged with overseeing the ban. But doubts about the bill, which was only released last week, have expanded from the pair to more mainstream Coalition MPs, setting up the meeting as a test of the opposition leader’s authority after he hauled his party room into line on abortion earlier this month. On Sunday night, the MPs were informed Monday’s meeting was cancelled, with the conversation to take place on Tuesday as part of the Coalition’s party room meeting. The Coalition leadership remains confident of overwhelming support for the bill inside the party, according to several opposition sources speaking anonymously about internal dynamics. Dutton, whose office declined to comment, plans to hear out his concerned colleagues but ultimately expects the party to back the bill, allowing it to pass parliament this week. The opposition rode a wave of conservative and libertarian campaigning against Labor’s misinformation bill in recent months before the government dropped its plan to crack down on falsehoods online on Sunday. Some of the groups and people behind that campaign, including One Nation, the Libertarian Party and former Coalition MPs George Christensen and Craig Kelly, have launched an email crusade about the social media age barrier that has resulted in complaints flooding into MPs inboxes. They endorse the view of X owner Elon Musk, who wrote on the platform last month that the ban “seems like a backdoor way to control access to the internet by all Australians” because it could require users to prove their identities before accessing major online services. Communications Minister Michelle Rowland was asked about the need to hand over ID in a Labor caucus meeting last week and said her laws would not force people to give ID documents to social media giants, dismissing the prospect as a right-wing scare campaign. However, the government has not announced the technology that would be used to prove a user’s age. ‘A red flag’ LNP MP Garth Hamilton said Labor had rushed the legislation and sent mixed signals about details such as which platforms would be included. The Wiggles successfully lobbied to allow YouTube to remain while Snapchat will be banned, though both apps now also have a TikTok-style feed of clips. “The tests for this bill are that it should not be a proxy for digital ID [to be required to access the internet] and that it actually responds to parents’ needs,” Hamilton said.“I fully agree with Peter Dutton’s concerns about the impacts of social media, and they are long-held. But Labor has had a long time to get details right [and] the utter confusion on the detail is a red flag.” Loading Coleman, who first proposed a teen ban in an April interview with this masthead at a time when Labor opposed such a change , told opposition MPs last week that the government could use a “double-blind tokenised approach” suggested by the eSafety Commission last year. That would allow a third party to verify a user’s age on a social media platform without revealing the identity information used to do so, while another option could force companies that operate app stores, such as Google and Apple, to take on the role. Labor announced the ban early this month after years of claims that social media was harming children’s mental health, much of which is disputed by the technology giants, and argued that it would bolster parents’ ability to reject pestering from kids to go online. But detractors including Ben Thompson, the boss of major Australian tech firm Employment Hero, said on X that bill would make it harder for children with special needs to make friends online. “Not to mention that it’s a Trojan Horse for digital ID and further censorship,” he said. On Sunday, Greens communications spokeswoman Sarah Hanson-Young called advocates for the ban well-intentioned, but said the bill was rushed compared to the government’s halting approach to gambling reform. “The government and the opposition are ramming through a ban on social media that was introduced on Thursday,” she said on ABC’s Insiders . “We’ve got a joke of a Senate inquiry for three days tomorrow. But they can’t do gambling ... Talk about priorities.” Cut through the noise of federal politics with news, views and expert analysis. Subscribers can sign up to our weekly Inside Politics newsletter . Save Log in , register or subscribe to save articles for later. License this article Social media Peter Dutton Anthony Albanese Paul Sakkal is federal political correspondent for The Age and Sydney Morning Herald who previously covered Victorian politics and has won two Walkley awards. Connect via Twitter . Most Viewed in Politics LoadingDodgers announce 5-year contract with LHP Blake SnellIPL 2025: Punjab Kings acquire Maxwell for Rs 4.20cr, Marsh to Lucknow

VW faces ultimatum as 2025 strikes loom

'Economic stability depends on peace, harmony'

Senator Alli Celebrates Oyo APC Leader, BAO At 85

Frenchman who sleeps with alligators seeks refuge for venomous menagerie COURON, France: His neighbours have cats and dogs, but when 72-year-old Philippe Gillet settles down to watch television there is usually an alligator dozing beside him. His bungalow in western France is also home to a venomous Gabonese viper, a spitting cobra, a python, alligator turtles that can bite off a finger, tarantulas and scorpions. When someone unfamiliar enters Gillet ́s living room, Gator, a two-metre-long alligator, growls from under a coffee table. “Calm down,” said Gillet and Gator went back to his snooze near Alli, another dozing alligator. “When there is a storm he comes to sleep in my bed,” said Gillet. “People think I am mad.” Videos of such episodes and other everyday tales of his deadly menagerie of 400 animals have made Gillet a social media star. They also promote his Inf ́Faune charity which aims to educate people about the animals he is so passionate about. Gillet lived in Africa for 20 years, working as a hunting guide. He said he would often catch crocodiles there to keep them away from villages. Back in France, he became a herpetologist -- a specialist on reptiles and amphibians. He made his base in Coueron, west of Nantes, with his partner, their children, and the animals. In the garden is Nilo, a Nile crocodile, who Gillet said was “one of the most dangerous species”. Chickens wandered by scratching for food. Most of the animals were bought or given to him by people who could no longer care for them. France ́s customs department has also sometimes turned to him.It’s a myth that you can’t monetise India promise: Figma’s Dylan FieldA Closer Look at 7 Analyst Recommendations For Omnicom Group

Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of the monthly cost. For Griffin, the hardest part of using the new drugs wasn’t access. It was finding out that the much-hyped medications didn’t really work for her. “I have been on Wegovy for a year and a half and have only lost 13 pounds,” said Griffin, who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight. Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. It's a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results. “It's all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight — and a person's response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives. “This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient. Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge. “It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.” That was the case for Griffin, who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.” The medications are typically prescribed along with eating behavior and lifestyle changes. It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases. For some patients, that just doesn't happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options. “I tell them: It's not game over,” Dushay said. Trying a different version of the new class of drugs may help. Griffin, who didn't respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds. “I'm hoping it's slow and steady,” she said. Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted. “Obesity is such a complex disease that really needs to be treated very comprehensively,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.” ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content. Jonel Aleccia, The Associated PressBulls look for inspiration to snap slump against inconsistent Hawks

RiverNorthPhotography Flagstar Q3 Review: Flagstar Financial's ( NYSE: FLG ), the old NYCB, Q3 results disappointed some investors. I believe an increase in guidance for a provision for loan losses and lower net interest income and net interest margin for this year, 2025, and 2026 are not Members of Catalyst Hedge Investing had early access to this article. They have exclusive access to many other articles every month as well as an active chat board with regular updates on ideas and a best ideas portfolio. Cashfow Hunter has over 25 years of experience in the markets, with nearly 20 of them as a hedge fund portfolio manager. His experience investing in debt and equity markets gives him unique insights into markets. He successfully predicted the implosion of Silicon Valley Bank. He has degrees from Wharton and MIT. He leads the investing group Catalyst Hedge Investing , in which he shares his best long and short ideas. He looks for investment ideas with asymmetric risk/reward and a clear catalyst. Learn More . Analyst’s Disclosure: I/we have a beneficial long position in the shares of FLG either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.Dodgers announce 5-year contract with LHP Blake Snell

The Latest: UnitedHealthcare shooting suspect contests his extradition back to New York